Inflammatory synovial fluid microenvironment drives primary human chondrocytes to actively take part in inflammatory joint diseases. (Q52617097)

4 May 2018

title

Inflammatory synovial fluid microenvironment drives primary human chondrocytes to actively take part in inflammatory joint diseases. (English)

1 reference

4 May 2018

main subject

inflammation

0 references

author

Gerd-Rüdiger Burmester

6

object named as

Gerd-Rüdiger Burmester

1 reference

4 May 2018

Eric Röhner

1

1 reference

4 May 2018

Georg Matziolis

2

1 reference

4 May 2018

Carsten Perka

3

1 reference

4 May 2018

Bernd Füchtmeier

4

1 reference

4 May 2018

Timo Gaber

5

1 reference

4 May 2018

Frank Buttgereit

7

1 reference

4 May 2018

Paula Hoff

8

1 reference

4 May 2018

publication date

1 June 2012

1 reference

4 May 2018

published in

Immunologic Research

1 reference

4 May 2018

volume

52

1 reference

4 May 2018

issue

3

1 reference

4 May 2018

page(s)

169-175

1 reference

4 May 2018

Chemokines and their receptors in rheumatoid arthritis: future targets?

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Chemokines and chemokine receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Chemokines in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Chemokines: their role in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Cytokine and chemokine gene expression of IL-1beta stimulated equine articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Induced apoptosis of chondrocytes by Porphyromonas gingivalis as a possible pathway for cartilage loss in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Mechanisms of Disease: angiogenesis in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Increased expression of macrophage migration inhibitory factor during fracture healing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8247-5

Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis

21 January 2018

1 reference

12 December 2020

Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis

1 reference

12 December 2020

Different cytokine profiles in patients with chronic and acute reactive arthritis.

1 reference

12 December 2020

Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts

1 reference

12 December 2020

Biological therapy for psoriatic arthritis in clinical practice: outcomes up to 2 years

1 reference

12 December 2020

Disease activity and cytokine production in mitogen-stimulated peripheral blood mononuclear cells from patients with rheumatoid arthritis

1 reference

12 December 2020

Differential chemokine receptor expression and function in human monocyte subpopulations

1 reference

12 December 2020

Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.

1 reference

12 December 2020

Modulatory effect of rhein on IL-1alpha-induced responses in human chondrocytes: a comparative study between antibody microarrays and specific ELISAs.

1 reference

12 December 2020

Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture

1 reference

12 December 2020

Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis

1 reference

12 December 2020

Apoptotic chondrocyte death in rheumatoid arthritis

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

12 December 2020

The role of cytokines in osteoarthritis pathophysiology

1 reference

12 December 2020

Angiogenesis in arthritis: methodological and analytical details

1 reference

12 December 2020

Review: angiogenesis: implications for rheumatoid arthritis

1 reference

12 December 2020

Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis

1 reference

12 December 2020

Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations

1 reference

12 December 2020

10.1007/S12026-011-8247-5

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018